MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced results from two prespecified analyses from the Phase 3 CLEAR (Cholesterol Lowering via Bempedoic Acid, an ...
CEDHARS is pleased to announce the recipients of its spring 2023 pilot grant funding opportunity, “Secondary Data Analysis to Advance Health or Rehabilitation Outcomes Research in People with ...
Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19) Clinical trials frequently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results